An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide association studies, whole-exome sequencing projects, and advanced statistical modeling to illuminate the polygenic architecture that underpins these heterogeneous neurological disorders. The synthesis, led by Dr. Olav B. Smeland of the Centre for Precision Psychiatry at Oslo University Hospital and the University of Oslo, draws a detailed portrait of a genetic landscape far more intricate than early twin studies ever suggested.
Epilepsy is not one disease. It is a constellation of seizure disorders that affects approximately 50 million people globally and carries increased mortality, psychiatric comorbidity, and,…